New CAPS pill shows promise in tiny early trial
Disease control
Recruiting now
This study tests an experimental drug called JTE-162 in 5 adults with CAPS, a rare genetic disease that causes fever, rash, and joint pain. Participants take one pill daily for 2 weeks. Researchers will check if the drug reduces inflammation and symptoms safely. This is an early-…
Phase: PHASE1 • Sponsor: Akros Pharma Inc. • Aim: Disease control
Last updated May 11, 2026 20:38 UTC